Schizophrenia trials in India

In India 10 Also abroad 473

10 trials · From ClinicalTrials.gov, checked 11 November 2026. Ask the study team whether a trial fits you.

Phase 3Taking people
A Study to Evaluate the Long-term Safety and Tolerability of Xanomeline and Trospium Chloride for the Treatment of Psychiatric Disorders in Children and Adolescents
Where
Kanpur, Kozhikode, Nagpur
Age
5 years to 17 years
People
400 worldwide
Run by
Karuna Therapeutics, Inc., a Bristol Myers Squibb company
See details and how to joinNCT07424404 · EU 2025-524062-16-00
Phase 3Taking people
A Study to Evaluate KarXT as a Treatment for Psychosis Associated With Alzheimer's Disease (ADEPT-4)
Where
Ajmer, Chandigarh, Chhatrapati Sambhajinagar, Hyderabad, Kolkata, Nagpur, Varanasi
Age
55 years to 90 years
People
406 worldwide
Run by
Karuna Therapeutics, Inc., a Bristol Myers Squibb company
See details and how to joinNCT06585787 · EU 2024-516363-92-00
Phase 2Taking people
A Study of Brenipatide in Adult Participants With Schizophrenia
Where
Bhopal, Chhatrapati Sambhajinagar, Dharwad, Karjat, Kolhāpur, Lucknow, Navi Mumbai, Pune, Tiruchirappalli
Age
18 years to 55 years
People
450 worldwide
Run by
Eli Lilly and Company
See details and how to joinNCT07410507
No phaseNot yet taking people in India
Prucalopride for Cognitive Functioning in Schizophrenia
Where
Mangalore
Age
18 years to 55 years
People
34
Run by
University of Pittsburgh
See details and how to joinNCT06474286
No phaseNot yet taking people in India
Feasibility and Acceptability of Mobile Mental Health App for SZ and SZA
Where
Palakkad
Age
18 years to 60 years
People
44
Run by
University of Pittsburgh
See details and how to joinNCT06474325
Phase 1Taking people
Evaluate Pharmacokinetics, Safety, and Tolerability of AX251 LAI in Patients With Schizophrenia
Where
Ahmedabad, Gandhinagar, Nagar
Age
18 years to 65 years
People
48
Run by
Anxo Pharmaceutical Co., Ltd.
See details and how to joinNCT07484204
Phase 3Taking people
Evenamide, a Glutamate Release Modulator, as Add-On to Standard of Care in Subjects With Documented Treatment-Resistant Schizophrenia
Where
Bībīnagar, Guwahati, Kolkata, Lucknow, Madurai, Mumbai, Nagpur, Navi Mumbai, Vijayawada
Age
18 years and over
People
400 worldwide
Run by
Newron Pharmaceuticals SPA
See details and how to joinNCT07184619
No phaseNot yet taking people in India
Comparison of Accelerated Intermittent Theta Burst Stimulation vs High Frequency Transcranial Magnetic Stimulation (Hf-rTMS) on Cognitivesymptoms in Treatment-resistant Schizophrenia
Where
Bhubaneswar
Age
18 years to 60 years
People
90
Run by
All India Institute of Medical Sciences, Bhubaneswar
See details and how to joinNCT07445620
Phase 1/2Taking people
Acetazolamide for Treatment Resistant Schizophrenia
Where
Bangalore
Age
18 years to 55 years
People
60 worldwide
Run by
Vishwajit Nimgaonkar, MD PhD
See details and how to joinNCT04887792
Phase 1/2Taking people
Pharmacokinetics, Safety, Tolerability and Efficacy of a Subcutaneous Long-Acting Injection of Cariprazine (Cariprazine Depot) in Subjects Eligible for Treatment With Oral Cariprazine
Where
Ahmedabad
Age
18 years to 64 years
People
24 worldwide
Run by
Mapi Pharma Ltd.
See details and how to joinNCT07185815